CC-11006

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameCC-11006
Drug Alias NameCC-11006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 beta inhibitorsInterleukin-10 stimulants
TargetsInterleukin-1 betaInterleukin-10
Therapy Area/IndicationsMyelodysplastic Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene Corp
Active IndicationsN/A
Inactive IndicationsMyelodysplastic Syndromes

Other Information

ATC CodeN/A
Related LinksN/A